Compare Divis Laboratories with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs ALKEM LABORATORIES - Comparison Results

DIVIS LABORATORIES     Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES ALKEM LABORATORIES DIVIS LABORATORIES/
ALKEM LABORATORIES
 
P/E (TTM) x 32.2 - - View Chart
P/BV x 7.3 6.5 112.3% View Chart
Dividend Yield % 0.6 0.7 92.2%  

Financials

 DIVIS LABORATORIES   ALKEM LABORATORIES
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-18
ALKEM LABORATORIES
Mar-16
DIVIS LABORATORIES/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs1,1421,589 71.9%   
Low Rs5331,232 43.3%   
Sales per share (Unadj.) Rs146.6417.5 35.1%  
Earnings per share (Unadj.) Rs33.056.3 58.7%  
Cash flow per share (Unadj.) Rs38.464.7 59.4%  
Dividends per share (Unadj.) Rs10.0012.70 78.7%  
Dividend yield (eoy) %1.20.9 132.6%  
Book value per share (Unadj.) Rs222.8292.9 76.1%  
Shares outstanding (eoy) m265.47119.57 222.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x5.73.4 169.1%   
Avg P/E ratio x25.325.1 101.2%  
P/CF ratio (eoy) x21.821.8 100.0%  
Price / Book Value ratio x3.84.8 78.1%  
Dividend payout %30.322.6 134.2%   
Avg Mkt Cap Rs m222,318168,653 131.8%   
No. of employees `00010.8NA-   
Total wages/salary Rs m4,5619,171 49.7%   
Avg. sales/employee Rs Th3,616.0NM-  
Avg. wages/employee Rs Th423.8NM-  
Avg. net profit/employee Rs Th814.9NM-  
INCOME DATA
Net Sales Rs m38,91549,915 78.0%  
Other income Rs m1,1341,645 69.0%   
Total revenues Rs m40,04951,561 77.7%   
Gross profit Rs m12,6178,482 148.7%  
Depreciation Rs m1,4251,006 141.7%   
Interest Rs m13671 2.0%   
Profit before tax Rs m12,3138,451 145.7%   
Minority Interest Rs m0-114 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,5431,606 220.6%   
Profit after tax Rs m8,7706,731 130.3%  
Gross profit margin %32.417.0 190.8%  
Effective tax rate %28.819.0 151.4%   
Net profit margin %22.513.5 167.1%  
BALANCE SHEET DATA
Current assets Rs m45,35127,062 167.6%   
Current liabilities Rs m6,50715,324 42.5%   
Net working cap to sales %99.823.5 424.5%  
Current ratio x7.01.8 394.6%  
Inventory Days Days12767 190.5%  
Debtors Days Days9541 230.5%  
Net fixed assets Rs m21,16012,610 167.8%   
Share capital Rs m531239 222.0%   
"Free" reserves Rs m58,62534,490 170.0%   
Net worth Rs m59,15635,027 168.9%   
Long term debt Rs m01,212 0.0%   
Total assets Rs m67,83254,387 124.7%  
Interest coverage x926.813.6 6,813.7%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.60.9 62.5%   
Return on assets %12.913.6 95.1%  
Return on equity %14.819.2 77.1%  
Return on capital %20.824.9 83.8%  
Exports to sales %012.9 0.0%   
Imports to sales %21.83.1 706.6%   
Exports (fob) Rs mNA6,461 0.0%   
Imports (cif) Rs m8,4851,540 550.9%   
Fx inflow Rs m32,3596,563 493.0%   
Fx outflow Rs m9,0423,012 300.2%   
Net fx Rs m23,3173,552 656.5%   
CASH FLOW
From Operations Rs m7,7597,259 106.9%  
From Investments Rs m-4,7831,864 -256.6%  
From Financial Activity Rs m-3,142-9,273 33.9%  
Net Cashflow Rs m-166-150 110.7%  

Share Holding

Indian Promoters % 52.0 66.9 77.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 11.8 33.1 35.6%  
FIIs % 19.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 17.2 0.0 -  
Shareholders   31,796 68,381 46.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   SHASUN PHARMA  WYETH LTD  GSK PHARMA  UNICHEM LAB  DR. REDDYS LAB  

Compare DIVIS LABORATORIES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Rising Petrol and Diesel Prices, DHFL Saga, and Top Cues in Focus Today(Pre-Open)

Indian share markets ended their trading session marginally higher yesterday. On the sectoral front, gains were seen in the metal sector and realty sector.

Related Views on News

DIVIS LABORATORIES Announces Quarterly Results (1QFY20); Net Profit Up 0.4% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 0.4% YoY). Sales on the other hand came in at Rs 11 bn (up 14.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (4QFY19); Net Profit Up 10.6% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 10.6% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (3QFY19); Net Profit Up 68.9% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (up 68.9% YoY). Sales on the other hand came in at Rs 13 bn (up 29.4% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES 2017-18 Annual Report Analysis (Annual Result Update)

Jan 1, 2019 | Updated on Jan 1, 2019

Here's an analysis of the annual report of DIVIS LABORATORIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

DIVIS LABORATORIES Announces Quarterly Results (2QFY19); Net Profit Up 92.3% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (up 92.3% YoY). Sales on the other hand came in at Rs 13 bn (up 44.3% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DIVIS LABORATORIES SHARE PRICE


Sep 18, 2019 (Close)

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES 5-YR ANALYSIS

COMPARE DIVIS LABORATORIES WITH

MARKET STATS